Real-world utilisation of ASCT in multiple myeloma (MM): a report from the Australian and New Zealand myeloma and related diseases registry (MRDR)-Reference-Cited by-同舟云学术

Real-world utilisation of ASCT in multiple myeloma (MM): a report from the Australian and New Zealand myeloma and related diseases registry (MRDR)

Published:2021-05-19 Issue:10 Volume:56 Page:2533-2543
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Bergin Krystal,Wellard Cameron^ORCID,Augustson Bradley,Cooke Rachel,Blacklock Hilary,Harrison Simon J.^ORCID,Ho Joy,King Tracy,Quach Hang,Mollee Peter,Walker Patricia,Moore Elizabeth^ORCID,McQuilten Zoe,Wood Erica,Spencer Andrew^ORCID,

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-021-01308-8.pdf

Reference48 articles.

1. Kyle RA, Steensma DP. History of multiple myeloma. Recent Results Cancer Res. 2011;183:3–23.

2. Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Pandey S, et al. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia. 2014;28:1122–8.

3. Naymagon L, Abdul-Hay M. Novel agents in the treatment of multiple myeloma: a review about the future. J Hematol Oncol. 2016;9:52.

4. Moreau P, Richardson PG, Cavo M, Orlowski RZ, San Miguel JF, Palumbo A, et al. Proteasome inhibitors in multiple myeloma: 10 years later. Blood. 2012;120:947–59.

5. Varga C, Laubach JP, Anderson KC, Richardson PG. Investigational agents in immunotherapy: a new horizon for the treatment of multiple myeloma. Br J Haematol. 2018;181:433–46.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developing and validating a discrete-event simulation model of multiple myeloma disease outcomes and treatment pathways using a national clinical registry;PLOS ONE;2024-08-27

2. Update on the outcome of M‐protein screening program of multiple myeloma in China: A 7‐year cohort study;Cancer Medicine;2023-12-22

3. Real-world multiple myeloma risk factors and outcomes by non-Hispanic Black/African American and non-Hispanic White race/ethnicity in the United States;Haematologica;2023-11-30

4. The obesity paradox in multiple myeloma: A report from Multiple Myeloma Research Foundation (MMRF) dataset;Cancer Medicine;2023-11-06

5. Real‐world multiple myeloma front‐line treatment and outcomes by transplant in the United States;eJHaem;2023-08-04